We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.09%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$868M
AUM Growth
-$190M
(-18%)
Cap. Flow
-$158M
Cap. Flow
% of AUM
-18.16%
Top 10 Holdings %
Top 10 Hldgs %
41.09%
Holding
110
New
31
Increased
14
Reduced
16
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$27.2M |
| 2 |
Microsoft
MSFT
|
+$23.1M |
| 3 |
RenaissanceRe
RNR
|
+$17.3M |
| 4 |
Visa
V
|
+$15.6M |
| 5 |
Mattel
MAT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$38.6M |
| 2 |
XPO
XPO
|
+$22.8M |
| 3 |
Cigna
CI
|
+$20.6M |
| 4 |
Cameco
CCJ
|
+$16M |
| 5 |
BWX Technologies
BWXT
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.19% |
| 2 | Industrials | 14.11% |
| 3 | Technology | 8.8% |
| 4 | Consumer Discretionary | 8.52% |
| 5 | Financials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Celestica
CLS
$36.5B
| $4.9M | 0.56% |
+200,000
| New | +$4.09M |
|
52
DexCom
DXCM
$32B
| $4.89M | 0.56% |
+52,400
| New | +$5.91M |
|
|
OPTN
53
DELISTED
OptiNose
OPTN
| $4.55M | 0.52% |
246,616
+3,334
| +1% | +$60K |
|
54
MGP Ingredients
MGPI
$375M
| $4.3M | 0.5% |
+40,800
| New | +$4.62M |
|
55
SCYNEXIS
SCYX
$52M
| $4.28M | 0.49% |
234,644
+18,770
| +9% | +$448K |
|
|
AKRO
56
PUT
DELISTED
Akero Therapeutics
AKRO
| $4.02M | 0.46% |
+79,500
| New | +$3.7M |
|
|
LUCK
57
Lucky Strike Entertainment
LUCK
$911M
| $3.94M | 0.45% |
410,000
-90,000
| -18% | -$990K |
|
58
CALL
Sunrun
RUN
$2.46B
| $3.77M | 0.43% |
+300,000
| New | +$4.93M |
|
59
Garrett Motion
GTX
$5.57B
| $3.74M | 0.43% |
475,000
+25,000
| +6% | +$192K |
|
60
Beyond Air
XAIR
$3.86M
| $3.15M | 0.36% |
3,409
| – | – |
|
61
Great Elm Group
GEG
$69.3M
| $2.95M | 0.34% |
1,379,049
| – | – |
|
62
Olema Pharmaceuticals
OLMA
$1.05B
| $2.59M | 0.3% |
+210,000
| New | +$2.14M |
|
|
LGF.A
63
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $2.33M | 0.27% |
275,000
-325,000
| -54% | -$2.58M |
|
64
CALL
Credo Technology Group
CRDO
$46.6B
| $2.29M | 0.26% |
+150,000
| New | +$2.37M |
|
65
X4 Pharmaceuticals
XFOR
$460M
| $2.15M | 0.25% |
65,789
| – | – |
|
66
Jasper Therapeutics
JSPR
$23.6M
| $2.13M | 0.25% |
304,000
| – | – |
|
67
Curis
CRIS
$7.83M
| $2.04M | 0.23% |
15,458
+9,147
| +145% | +$2.35M |
|
68
Sol-Gel Technologies
SLGL
$288M
| $1.25M | 0.14% |
76,686
-411
| -0.5% | -$11.8K |
|
|
69
CALL
Olema Pharmaceuticals
OLMA
$1.05B
| $1.22M | 0.14% |
+98,600
| New | +$1.01M |
|
|
NVNO
70
enVVeno Medical
NVNO
$7.09M
| $1.18M | 0.14% |
6,262
| – | – |
|
|
NB
71
NioCorp Developments
NB
$780M
| $1.14M | 0.13% |
314,465
| – | – |
|
|
VINC
72
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $389K | 0.04% |
19,250
| – | – |
|
73
Ameresco
AMRC
$1.36B
| – | – |
-95,000
| Closed | -$4.62M |
|
74
PUT
BridgeBio Pharma
BBIO
$16.5B
| – | – |
-267,500
| Closed | -$4.6M |
|
75
CALL
Blackstone
BX
$110B
| – | – |
-400,000
| Closed | -$37.2M |
|
Similar funds
GC
ICP
SAA
GIG
SI
PAMI
BDP
PTC
Kingdon Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Kingdon Capital Management held 110 positions worth $868M, down 18% from $1.06B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Kingdon Capital Management withdrew a net $158M in Q3 2023, closing 38 positions and reducing 16 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $38.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.
Against the trend, Kingdon Capital Management opened a new position in Danaher worth $26.8M.
- Kingdon Capital Management's largest Q3 2023 buy was Danaher: 121,937 shares worth $26.8M.
- Kingdon Capital Management added most to R1 RCM Inc. Common Stock in Q3 2023, an estimated $6.22M increase.
- Kingdon Capital Management's biggest Q3 2023 reduction was BWX Technologies, cutting an estimated $12.3M.
- Kingdon Capital Management fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $38.6M.
- Kingdon Capital Management's ten largest holdings make up 41% of its $868M portfolio in Q3 2023.
- Kingdon Capital Management opened 31 new positions and closed 38 in Q3 2023.
- Kingdon Capital Management's portfolio value fell 18% quarter-over-quarter to $868M.
Based on Kingdon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.